Huizenga Theodore Alan - Insider Non-Derivative Transactions at Ultragenyx Pharmaceutical Inc. (RARE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 16, 2024, Huizenga Theodore Alan's relationship to Ultragenyx Pharmaceutical Inc. (RARE) is Officer (SVP, Chief Accounting Officer), and currently has 42,251 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RARE insiders.

Data Source: SEC.
Huizenga Theodore Alan - Insider Non-Derivative Transactions of RARE Common Stock
Huizenga Theodore Alan - Insider Non-Derivative Transactions at RARE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 17, 2024 Acquisition -- (Common Stock) 700 0 42251
Sep 4, 2024 Sell -- (Common Stock) 91 56.19 41551
Apr 17, 2024 F -- (Common Stock) 14 42.31 41366
Mar 2, 2024 Sell -- (Common Stock) 341 53.76 41380
Mar 2, 2024 F -- (Common Stock) 121 53.69 41721
Mar 2, 2024 Acquisition -- (Common Stock) 13950 0 41842
Jan 3, 2024 M -- (Common Stock) 3000 21 27892
Dec 21, 2023 Acquisition -- (Common Stock) 1000 0 24614
Sep 8, 2023 Sell -- (Common Stock) 163 38.34 23614
Sep 8, 2023 Sell -- (Common Stock) 2000 41 23777
Sep 8, 2023 M -- (Common Stock) 2000 21 25777
Sep 2, 2023 Sell -- (Common Stock) 87 38.23 23777
Sep 2, 2023 Sell -- (Common Stock) 883 37.04 23864
May 10, 2023 M -- (Common Stock) 3000 21 30747
Apr 17, 2023 Disposition -- (Common Stock) 181 38.2 27520
Apr 17, 2023 F -- (Common Stock) 14 38.2 27701
Mar 2, 2023 Disposition -- (Common Stock) 1333 45.65 21715
Mar 2, 2023 Sell -- (Common Stock) 100 45.65 23048
Mar 2, 2023 Acquisition -- (Common Stock) 7590 0 23148
Mar 1, 2023 Sell -- (Common Stock) 639 43.4 15558